Health systems rarely struggle because of one broken revenue cycle task. They struggle because processes, teams, systems and data are not aligned. That is why fragmented improvement efforts often deliver limited gains. For organizations that need stronger cash performance, clearer accountability and more scalable operations, end-to-end revenue cycle management (RCM) is the strongest model.
Key takeaway: Point fixes can improve isolated issues. End-to-end RCM is the better fit because it brings accountability, unified data and broader performance improvement into one model.
What leaders need to know
When searching for an RCM partner, consider:
- Consultants can diagnose issues, but they do not own execution or outcomes.
- Point solutions can improve a specific function, but they limit exposure to the entire encounter, creating data blind spots that starve reasoning models within the interconnected journey to solve complex problems.
- Tech-only tools can create an illusion of efficiency, but without embedded expert management, they may automate bad processes faster rather than solving root-cause variances.
- End-to-end RCM partnerships combine operations, accountability and technology in one model, making them better suited to complex health systems.
Why choose revenue cycle outsourcing vs. insourcing?
Running revenue cycle operations in-house gives health systems direct control, but control alone does not guarantee performance. Many organizations that keep RCM internal still face staffing shortages, outdated technology and inconsistent processes — leaving them with facility-level blind spots that fail to catch changing payer rules.
When those challenges compound, internal teams spend more time managing day-to-day operations than driving meaningful improvement. The result is often flat or declining cash performance despite significant investment in people and tools.
Outsourcing shifts this operating model. A dedicated RCM partner brings specialized expertise, purpose-built technology and a workforce scaled to handle volume across the full revenue cycle. Just as important, outsourcing introduces external accountability — something most in-house teams lack.
"We went through a pretty exhaustive process when deciding whether to insource, outsource, or do a hybrid approach. We realized that even though we said we were insourced, we were actually working with several revenue cycle firms and managing vendor relationships. There were gaps, and things were getting missed. We had a lot of internal employees doing great work, but when it came to the technical aspects and the nuance of collecting, things were too fragmented. We needed one source of truth and one partner to hold accountable…"
Rather than distributing ownership across departments with competing priorities, a strong partner consolidates responsibility under one model with clear performance expectations. For health systems navigating margin pressure, payer complexity and growing operational demands, that shift from ownership to accountability is often what separates incremental progress from enterprise-wide improvement.
Why fragmented RCM underperforms
Fragmented RCM often underperforms because it means multiple vendors, siloed data, inconsistent processes and shared accountability. The fragmentation means a lack of end-to-end reasoning models, which leads to difficulty solving problems with speed and value.
"...Having a single partner with a singular focus who brings accountability and investment has been a game changer compared to juggling multiple vendors."
These five common silos in RCM routinely produce costly blind spots for health systems:
- CDI optimization without downstream accountability: CDI vendors may be rewarded for increasing case mix index and DRG weight without being held responsible when aggressive coding leads to denials or audits. The result is higher DRGs that may not hold up under review, creating denials that take additional time and resources to resolve.
- DRG validation that catches errors after money is at risk: DRG validation is typically performed after discharge and claim submission, which means it identifies coding issues too late to prevent them. While it can still detect errors, it offers limited value as a true prevention strategy.
- Underpayment recovery that monetizes the symptom: Underpayment recovery is often contingency-based, with vendors taking 15%–25% of recovered revenue. That model creates little incentive to fix root causes such as contract terms or recurring payer behavior. As a result, the same underpayments can continue and the organization keeps paying to recover revenue it should have received in the first place.
- Denial management that does not address the source of denials: Denial management vendors may be paid based on appeals volume and overturn rates, but they often cannot change the upstream EMR processes causing the denials. As a result, the work becomes reactive — more appeals are filed while the underlying denial patterns continue.
- Complex claims support without system-wide insight: Complex claims specialists may focus on high-dollar cases one at a time without visibility into the broader issues making those claims difficult. That case-by-case approach may resolve individual claims, but it does not fix the recurring patterns behind the complexity.
For health systems, each of these factors can slow decision-making, reduce visibility across the revenue cycle and leave revenue leakage unresolved. The issue is not just tool performance. It is the lack of one operating model accountable for enterprise-wide results.
How do these RCM models compare?
Consultants (Advisory)
Scope
Advisory only. RCM consulting services offer broad RCM guidance, but no direct execution. Revenue cycle consulting is best for targeted projects or assessments.
Root-Cause Resolution
Limited follow-through. Can identify root causes, but the health system still must implement the fixes. Results depend on internal capacity.
Net Revenue Impact
Variable. Financial impact depends on how well recommendations are implemented. With revenue cycle management consulting, gains are often modest because accountability stays internal.
AI + Data Usability
Low. May use analytics during the engagement, but ongoing operational AI and data integration remain with the health system.
Point Solution Vendors
Scope
Narrow scope. Each tool addresses one part of RCM, such as coding, denials or billing. Full coverage usually requires many vendors and added integration effort.
Root-Cause Resolution
Partial improvement. Can solve a specific pain point, but often leaves upstream and downstream issues untouched. Shared ownership can keep root causes in place.
Net Revenue Impact
Incremental gains. A point solution can improve one metric, but enterprise-wide impact is limited when tools remain disconnected.
AI + Data Usability
Limited. Some vendors offer AI within their niche, but data stays siloed and cross-functional insight remains limited.
Tech/AI-Only Solutions
Scope
Task-level automation. Often improves selected processes such as claim edits, scheduling or billing processes. Broader impact depends on full integration and adoption.
Root-Cause Resolution
Focused improvement. Can reduce errors in targeted tasks, but broader operating issues often remain outside the tool’s scope.
Net Revenue Impact
Efficiency-driven ROI. Can reduce manual work and lower cost to collect, but revenue lift is usually task-specific and depends on adoption.
AI + Data Usability
High in specific processes. These tools can be advanced within their use case, but integration challenges often limit enterprise-wide insight.
End-to-End RCM Partnership
Scope
Enterprise-wide scope. Covers the full revenue cycle, from patient access through collections, under one accountable model. Aligns people, process and technology across the enterprise.
Root-Cause Resolution
High. Creates unified oversight across the entire encounter using data and reasoning, allowing teams to fix recurring issues at the source and prevent repeat problems.
Net Revenue Impact
Strongest upside. Broad improvement across yield, cash performance and leakage reduction. A leading RCM partner will often include outcome-based commitments.
AI + Data Usability
Highest. The right RCM partner will use unified data across the revenue cycle to support AI, prioritization and process-level decision-making at scale.
What to evaluate in an RCM partner
When assessing an RCM partnership, ask:
- Can the partner commit to measurable outcomes? Look for clear accountability tied to cash performance, denials, AR and related KPIs.
- Can the partner prove net revenue improvement? Ask for documented results in health systems with similar scale and complexity.
- Is the governance model strong enough? Confirm executive oversight, decision rights, reporting cadence and issue escalation.
- Are the AI + data capabilities enterprise-ready? Look for unified data, process integration and decision support that extends across the revenue cycle.
- Is the transition plan realistic? Assess staffing, change management, implementation timing and operational continuity.
- How will the partner elevate the patient experience? Look for digital tools and patient-centric capabilities that deliver a coordinated experience to improve access, reduce friction and enable fast action.
Learn more about how to identify the right end-to-end RCM partner for your organization.
"Ensemble is a true partner. When we experienced an IT disruption, Ensemble stepped up in a major way. They put in extra work and resources without passing additional costs on to us. Thanks to the firm, we recovered faster than most organizations would in a situation like that. That says everything about the strength of the partnership."
How do these RCM models compare?
Consultants (advisory only)
Key Strengths
Expert outside perspective and targeted strategic guidance.
Key Limitations
No implementation ownership and no guaranteed outcomes. Lacks execution ability; not sufficient for large-scale, ongoing improvements.
Best-Fit Scenario
Short-term assessment or strategy work when internal teams can execute.
Point Solutions
Key Strengths
Can improve a targeted issue and deliver quick wins.
Key Limitations
Creates fragmentation, leading to data blind spots that starve reasoning models; adds integration work; limits enterprise impact.
Best-Fit Scenario
Organizations filling specific gaps while keeping RCM in-house.
Tech/AI-Only Solutions
Key Strengths
Improves efficiency, reduces manual work and supports automation.
Key Limitations
Requires strong internal adoption, IT support and process discipline; otherwise, may automate bad processes faster, rather than solving root-cause variances.
Best-Fit Scenario
Organizations with automatable process bottlenecks and strong internal support.
End-to-End RCM Partnership
Key Strengths
Combines operations, accountability and technology in one model. Offers broadest scope, clearest accountability and strongest performance potential.
Key Limitations
Requires a major commitment, strong governance and a careful transition.
Best-Fit Scenario
Performance-focused systems seeking enterprise-wide improvement.
The bottom line
If the goal is targeted improvement, point fixes may help. If the goal is enterprise-wide performance improvement, health systems should evaluate end-to-end RCM first.
Independent market signals support the shift toward end-to-end partnerships for organizations seeking stronger financial stability and performance:
- KLAS End-to-End Revenue Cycle Outsourcing 2025
- 2026 Best in KLAS Awards
Black Book Research’s 2026 State of Health & Hospital Systems Revenue Cycle Management Technology & Services report
The end-to-end RCM model is the only definitive solution for hospitals and health systems ready to eliminate siloed visibility, inject full-counter context into reasoning models and unlock the enterprise-wide scale needed to maximize net revenue and outpace volatile payer policies.
